Pediatr Res 62(6):725730 van der Schoor LW, Verkade HJ, Bertolini A, de Wit S, Mennillo E, Rettenmeier E, Weber AA, Havinga R, Valkov P, Japrov J, Struik D (2021) Potential of therapeutic bile acids in the treatment of neonatal hyperbilirubinemia
M., Bonzel, K
Landmark studies such as LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown significant reductions in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors
Ho HY, Cheng ML, Chiu DT
Refer to Berberine combined with JPYSHZF improves ovarian function in PCOS rats PCOS is defined by the presence of polycystic ovarian changes and disrupted secretion of sex hormones
Enhances Skin Health Promotes a brighter, more even complexion